Premium
Design and analysis of efficacy evaluation trials
Author(s) -
The treatments in a completely randomized design (Fig.,
) are assigned at random to the experimental unit. This design is potentially the most powerful …,
because it allows retention of the maximum number of degrees of freedom for the residual variance. …,
it is suitable only if the trial area is known to offer a homogeneous environment. If there is …,
residual variance may become unacceptably high,
and it is better to use a design that accounts for this,
Stephan Block
Publication year - 2012
Publication title -
eppo bulletin
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.327
H-Index - 36
eISSN - 1365-2338
pISSN - 0250-8052
DOI - 10.1111/epp.2610
Subject(s) - scope (computer science) , drug approval , medicine , medical physics , risk analysis (engineering) , computer science , pharmacology , drug , programming language
Specific scope This standard is intended for use in association with EPPO Standards of set PP 1 S tandards for the efficacy evaluation of plant protection products and provides detailed advice on the design and analysis of efficacy evaluation trials. Specific approval and amendment First approved in 1989–09. First revision approved in 1998–09. Second revision approved in 2006–09. Revision mainly to reflect zonal assessment approved in 2012–09.